GLP-1 receptor agonists can be applied in clinical practice to aid in the management of weight, making people feel fuller and decreasing their total calories
Follow the suggested usage on the packaging or as directed by your healthcare provider
JRSM Cardiovasc Dis 11(8):2048004019843047 Correale M, Paolillo S, Mercurio V, Limongelli G, Barill F, Ruocco G, Palazzuoli A, Scrutinio D, Lagioia R, Lombardi C, Lupi L, Magr D, Masarone D, Pacileo G, Scicchitano P, Matteo Ciccone M, Parati G, Tocchetti CG, Nodari S (2020) Comorbidities in chronic heart failure: An update from Italian Society of Cardiology (SIC) Working Group on Heart Failure
Retatrutide's ~6-day half-life means that a 5-day dosing interval would administer the next dose before the drug has reached one half-life resulting in higher trough levels and faster accumulation to steady state